However, further investigation is warranted to comprehensively elucidate the intricate interactions between the JAK-STAT pathway and TILs in HCC, as well as to develop efficacious therapeutic strategies that harness these interactions for improved patient prognosis. The gene discussed is SOAT1; the disease is hepatocellular carcinoma.